Table 2 A comprehensive summary of indications for AATD testing across documents for the clinical management of chronic respiratory disease
Document | Disease | Indications for AATD testing |
|---|---|---|
Global strategy for prevention, diagnosis and management of COPD, 2018 [49] | COPD | All patients with a diagnosis of COPD, especially in areas with high AATD prevalence |
Global strategy for asthma management and prevention, 2018 [50] | Asthma | No indication for AATD testing |
European Respiratory Society, 2017 [54] | Bronchiectasis | Patients with basal emphysema or early onset airflow obstruction |
Pulmonology Portuguese Society Bronchiectasis Study Group, 2018 [53] | Bronchiectasis | All patients with a diagnosis of BE |
Thoracic Society of Australia and New Zealand, 2015 [62] | Bronchiectasis | No indication for AATD testing |
British Thoracic Society, 2010 [51] | Bronchiectasis | Patients with basal emphysema. |
Normativa SEPAR, 2008 [52] | Bronchiectasis | Patients with emphysema and /or liver disease |